Edition:
United Kingdom

Akcea Therapeutics Inc (AKCA.OQ)

AKCA.OQ on NASDAQ Stock Exchange Global Select Market

26.22USD
22 Jun 2018
Change (% chg)

$0.30 (+1.16%)
Prev Close
$25.92
Open
$25.97
Day's High
$27.80
Day's Low
$25.21
Volume
234,010
Avg. Vol
106,243
52-wk High
$33.86
52-wk Low
$8.10

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -1.20 December 23 Jun 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 0 0
(2) OUTPERFORM 1 1 1 1
(3) HOLD 2 2 3 3
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.25 2.25 2.75 2.75

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 4 12.56 15.73 7.50 --
Quarter Ending Sep-18 4 23.54 37.40 14.78 --
Year Ending Dec-18 4 105.08 153.00 73.36 --
Year Ending Dec-19 4 443.76 874.00 142.13 --
Earnings (per share)
Quarter Ending Jun-18 3 -1.20 -0.46 -2.48 --
Quarter Ending Sep-18 3 -0.59 -0.45 -0.77 --
Year Ending Dec-18 3 -2.64 -1.55 -3.98 --
Year Ending Dec-19 4 0.30 4.95 -1.52 --

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-18 12.12 17.11 4.98 41.11
Quarter Ending Dec-17 11.92 18.03 6.11 51.28
Quarter Ending Sep-17 11.91 13.45 1.54 12.95

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 12.56 12.56 12.56 12.12 --
Quarter Ending Sep-18 23.54 23.54 23.54 23.62 --
Year Ending Dec-18 105.08 105.08 105.08 84.03 --
Year Ending Dec-19 443.76 443.76 443.76 327.23 --

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jun-18 0 0 0 0
Quarter Ending Sep-18 0 0 0 0
Year Ending Dec-18 0 0 0 0
Year Ending Dec-19 0 0 0 0
Earnings